Olgu Sunumu
BibTex RIS Kaynak Göster

Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report

Yıl 2021, , 177 - 181, 01.07.2021
https://doi.org/10.7197/cmj.842870

Öz

Anti-tumor necrosis factor agents are effective drugs for inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. Although it is indicated for the treatment of Ankylosing Spondylitis, there are recent publications about paradoxical side effects due to these agents, mostly in the form of case reports. In this article, we present the psoriasis case that develops paradoxically in a patient with ankylosing spondylitis using adalimumab.

Kaynakça

  • 1.Esener, Sarenur, ve İnci Mevlitoğlu. “Pustular bakterid of Andrews during infiliximab therapy for ankylosing spondylitis: A case report”. TURKDERM 48, sy S2 (15 Haziran 2014): 105-7. https://doi.org/10.4274/turkderm.48.s27
  • 2. İpek, Serkan, Cem Çekiç, Emrah Alper, Zehra Akpınar, Hakan Çamyar, Mustafa Kartal, ve Belkıs Ünsal. “Ankilozan spondilit nedeniyle adalimumab kullanan bir hastada paradoksal olarak gelişen Crohn hastalığı”, t.y., 4.
  • 3. Koyun, Bilgesu, Eda Özalp, Oğuzhan Acet, ve Oytun Erbaş. “Romatolojik ve otoimmün hastalıklarda interlökin 23/tip 17 yardımcı T hücreleri yolağı için etkili güncel tedavi yöntemleri”. Demiroğlu Bilim Üniversitesi Florence Nightingale Transplantasyon Dergisi 3, sy 1 (2018): 025-030. https://doi.org/10.5606/fng.transplantasyon.2018.007.
  • 4. Böyük, Emine, Işıl Bulur, Zeynep Nurhan Saraçoğlu, Hilal Kaya Erdoğan, Deniz Arık. “Romatoid Artrit Tanısı ile Golimumab Tedavisi Alan Hastada Gelişen Palmoplantar Püstülozis”. http://www.dermatoz.org/archives/archive-detail/article-preview/romatoid-artrit-tans-ile-golimumab-tedavisi-alan-h/36602 (06 Ekim 2020)
  • 5. Pugliese, D., L. Guidi, P. M. Ferraro, M. Marzo, C. Felice, L. Celleno, R. Landi, vd. “Paradoxical Psoriasis in a Large Cohort of Patients with Inflammatory Bowel Disease Receiving Treatment with Anti-TNF Alpha: 5-Year Follow-up Study”. Alimentary Pharmacology & Therapeutics 42, sy 7 (Ekim 2015): 880-88. https://doi.org/10.1111/apt.13352.
  • 6. Soto Lopes, Marien Siqueira, Beatriz Moritz Trope, Maria Paula Rua Rochedo Rodriguez, Rachel Lima Grynszpan, Tullia Cuzzi, ve Marcia Ramos-E-Silva. “Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa”. Case Reports in Dermatology 5, sy 3 (2013): 326-31. https://doi.org/10.1159/000350930.
  • 7. Sarpel, Tunay, Sibel Basaran, Filiz Dogan Akcam, Suhan Gunasti, ve Yasargul Denli. “Psoriasis Induced by Tumor Necrosis Factor-Alpha Antagonist Therapy: Case Series and Literature Overview”. Turkish Journal of Rheumatology 25, sy 2 (01 Haziran 2010): 91-94. https://doi.org/10.5152/tjr.2010.09.
Yıl 2021, , 177 - 181, 01.07.2021
https://doi.org/10.7197/cmj.842870

Öz

Kaynakça

  • 1.Esener, Sarenur, ve İnci Mevlitoğlu. “Pustular bakterid of Andrews during infiliximab therapy for ankylosing spondylitis: A case report”. TURKDERM 48, sy S2 (15 Haziran 2014): 105-7. https://doi.org/10.4274/turkderm.48.s27
  • 2. İpek, Serkan, Cem Çekiç, Emrah Alper, Zehra Akpınar, Hakan Çamyar, Mustafa Kartal, ve Belkıs Ünsal. “Ankilozan spondilit nedeniyle adalimumab kullanan bir hastada paradoksal olarak gelişen Crohn hastalığı”, t.y., 4.
  • 3. Koyun, Bilgesu, Eda Özalp, Oğuzhan Acet, ve Oytun Erbaş. “Romatolojik ve otoimmün hastalıklarda interlökin 23/tip 17 yardımcı T hücreleri yolağı için etkili güncel tedavi yöntemleri”. Demiroğlu Bilim Üniversitesi Florence Nightingale Transplantasyon Dergisi 3, sy 1 (2018): 025-030. https://doi.org/10.5606/fng.transplantasyon.2018.007.
  • 4. Böyük, Emine, Işıl Bulur, Zeynep Nurhan Saraçoğlu, Hilal Kaya Erdoğan, Deniz Arık. “Romatoid Artrit Tanısı ile Golimumab Tedavisi Alan Hastada Gelişen Palmoplantar Püstülozis”. http://www.dermatoz.org/archives/archive-detail/article-preview/romatoid-artrit-tans-ile-golimumab-tedavisi-alan-h/36602 (06 Ekim 2020)
  • 5. Pugliese, D., L. Guidi, P. M. Ferraro, M. Marzo, C. Felice, L. Celleno, R. Landi, vd. “Paradoxical Psoriasis in a Large Cohort of Patients with Inflammatory Bowel Disease Receiving Treatment with Anti-TNF Alpha: 5-Year Follow-up Study”. Alimentary Pharmacology & Therapeutics 42, sy 7 (Ekim 2015): 880-88. https://doi.org/10.1111/apt.13352.
  • 6. Soto Lopes, Marien Siqueira, Beatriz Moritz Trope, Maria Paula Rua Rochedo Rodriguez, Rachel Lima Grynszpan, Tullia Cuzzi, ve Marcia Ramos-E-Silva. “Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa”. Case Reports in Dermatology 5, sy 3 (2013): 326-31. https://doi.org/10.1159/000350930.
  • 7. Sarpel, Tunay, Sibel Basaran, Filiz Dogan Akcam, Suhan Gunasti, ve Yasargul Denli. “Psoriasis Induced by Tumor Necrosis Factor-Alpha Antagonist Therapy: Case Series and Literature Overview”. Turkish Journal of Rheumatology 25, sy 2 (01 Haziran 2010): 91-94. https://doi.org/10.5152/tjr.2010.09.
Toplam 7 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Medical Science Research Makaleler
Yazarlar

Sena İrkin 0000-0002-7840-2451

Neşe Çabuk Çelik 0000-0002-9045-7105

Burak Karakaş 0000-0003-3624-4958

Beliz Karataş

Ali Şahin 0000-0002-6953-4276

Yayımlanma Tarihi 1 Temmuz 2021
Kabul Tarihi 30 Haziran 2021
Yayımlandığı Sayı Yıl 2021

Kaynak Göster

AMA İrkin S, Çabuk Çelik N, Karakaş B, Karataş B, Şahin A. Paradoxically Psoriasis, developed in a patient using adalimumab for ankylosing spondylitis: Case report. CMJ. Temmuz 2021;43(2):177-181. doi:10.7197/cmj.842870